This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of pharmaceutical agents. It plays a significant role in the development of drugs targeting central nervous system disorders, particularly as a precursor in the production of selective serotonin reuptake inhibitors (SSRIs) and other psychotropic medications. Its structural features, including the fluorophenyl and dimethylamino groups, contribute to its bioactivity and binding affinity to specific receptors in the brain. Additionally, it is employed in research settings to study the pharmacological properties of compounds designed to treat depression, anxiety, and related mental health conditions. Its hydrobromide salt form enhances stability and solubility, making it suitable for formulation and experimental use.